CN116492437B - 一种改善呼吸道免疫力的植物口含片及其制备工艺 - Google Patents
一种改善呼吸道免疫力的植物口含片及其制备工艺 Download PDFInfo
- Publication number
- CN116492437B CN116492437B CN202310295065.2A CN202310295065A CN116492437B CN 116492437 B CN116492437 B CN 116492437B CN 202310295065 A CN202310295065 A CN 202310295065A CN 116492437 B CN116492437 B CN 116492437B
- Authority
- CN
- China
- Prior art keywords
- respiratory tract
- parts
- improving
- composition
- tract immunity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000036039 immunity Effects 0.000 title claims abstract description 126
- 210000002345 respiratory system Anatomy 0.000 title claims abstract description 123
- 239000006189 buccal tablet Substances 0.000 title claims abstract description 51
- 229940046011 buccal tablet Drugs 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 73
- 239000003814 drug Substances 0.000 claims abstract description 47
- 241000196324 Embryophyta Species 0.000 claims abstract description 42
- 239000000284 extract Substances 0.000 claims abstract description 40
- 240000004307 Citrus medica Species 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 22
- 235000021092 sugar substitutes Nutrition 0.000 claims abstract description 11
- 239000003765 sweetening agent Substances 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims description 64
- 229940079593 drug Drugs 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 24
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 24
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 24
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 24
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 24
- 238000002156 mixing Methods 0.000 claims description 21
- 238000007873 sieving Methods 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 15
- 239000011248 coating agent Substances 0.000 claims description 13
- 238000000576 coating method Methods 0.000 claims description 13
- 238000000227 grinding Methods 0.000 claims description 13
- 238000010298 pulverizing process Methods 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 12
- 235000019359 magnesium stearate Nutrition 0.000 claims description 12
- 235000004879 dioscorea Nutrition 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 11
- 229920002774 Maltodextrin Polymers 0.000 claims description 10
- 239000005913 Maltodextrin Substances 0.000 claims description 10
- 229940035034 maltodextrin Drugs 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 10
- 238000005360 mashing Methods 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 8
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 229940041616 menthol Drugs 0.000 claims description 8
- 241000205585 Aquilegia canadensis Species 0.000 claims description 7
- 244000163122 Curcuma domestica Species 0.000 claims description 7
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 7
- 244000119298 Emblica officinalis Species 0.000 claims description 7
- 235000015489 Emblica officinalis Nutrition 0.000 claims description 7
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 7
- 244000062245 Hedychium flavescens Species 0.000 claims description 7
- 241001018563 Nekemias grossedentata Species 0.000 claims description 7
- 235000004347 Perilla Nutrition 0.000 claims description 7
- 244000124853 Perilla frutescens Species 0.000 claims description 7
- 244000203593 Piper nigrum Species 0.000 claims description 7
- 235000008184 Piper nigrum Nutrition 0.000 claims description 7
- 235000013614 black pepper Nutrition 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- 235000003373 curcuma longa Nutrition 0.000 claims description 7
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 7
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 7
- 235000011477 liquorice Nutrition 0.000 claims description 7
- 235000013976 turmeric Nutrition 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000000811 xylitol Substances 0.000 claims description 6
- 235000010447 xylitol Nutrition 0.000 claims description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 6
- 229960002675 xylitol Drugs 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 239000006286 aqueous extract Substances 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 229920000881 Modified starch Polymers 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 239000004386 Erythritol Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 244000246386 Mentha pulegium Species 0.000 claims description 2
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 2
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 2
- 235000019414 erythritol Nutrition 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- 229940009714 erythritol Drugs 0.000 claims description 2
- 239000007888 film coating Substances 0.000 claims description 2
- 238000009501 film coating Methods 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 235000001050 hortel pimenta Nutrition 0.000 claims description 2
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 claims description 2
- 229940057838 polyethylene glycol 4000 Drugs 0.000 claims description 2
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims description 2
- 235000012239 silicon dioxide Nutrition 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 17
- 206010011224 Cough Diseases 0.000 abstract description 16
- 206010036790 Productive cough Diseases 0.000 abstract description 13
- 208000006083 Hypokinesia Diseases 0.000 abstract description 10
- 208000032140 Sleepiness Diseases 0.000 abstract description 10
- 206010041349 Somnolence Diseases 0.000 abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 208000035475 disorder Diseases 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 208000036626 Mental retardation Diseases 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 5
- 238000011112 process operation Methods 0.000 abstract description 5
- 239000002562 thickening agent Substances 0.000 abstract description 4
- 239000000546 pharmaceutical excipient Substances 0.000 abstract description 3
- 244000269722 Thea sinensis Species 0.000 abstract description 2
- 230000003750 conditioning effect Effects 0.000 abstract description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 7
- 235000002899 Mentha suaveolens Nutrition 0.000 description 7
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 6
- 230000003340 mental effect Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010028748 Nasal obstruction Diseases 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 208000013220 shortness of breath Diseases 0.000 description 3
- 230000037321 sleepiness Effects 0.000 description 3
- 206010013789 Dry throat Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000008369 fruit flavor Substances 0.000 description 2
- 230000000521 hyperimmunizing effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 229940124531 pharmaceutical excipient Drugs 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000003670 sublingual gland Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 238000012418 validation experiment Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种改善呼吸道免疫力的植物口含片,按重量份计,包括以下组分:改善呼吸道免疫力组合物20~30份;香橼提取物15~20份;糖或代糖20~30份;增稠剂30~40份;清凉醇0.2~0.4份;药用辅料0.5~1份;水溶性老香橼食用香精0.5~1.5份;采用药食同源的草本免疫成分,对身体无毒副作用,能够通过人体多归经调理,综合改善呼吸道免疫力及其紊乱所致的咳嗽、咳痰、乏力、嗜睡、精神不济等症状。本发明还公开了一种改善呼吸道免疫力的植物口含片的制备工艺,使用直接压片法,成本低且工艺操作省时简单。
Description
技术领域
本发明涉及一种改善呼吸道免疫力的植物口含片及其制备工艺。
背景技术
当前呼吸道免疫力紊乱(免疫力过高或过低)的主要诱因为生态环境的恶化。外部环境的恶化导致呼吸道敏感性增强,从而易得各种呼吸道疾病,比如气管炎、支气管炎、肺炎、咽炎、扁桃体炎、上呼吸道感染、过敏反应等,疾病的长期反复发作,最终导致肺部免疫力紊乱。
为了缓解这一系列症状,有的人会选择购买市面上推出的清热茶饮,或吃清肺止咳药物等等,但对症效果参差不齐,且药物摄入后的毒副作用需要依赖肝脏去消除,无疑是再一次增加了身体负担。片剂具有体积小、质量稳定、易于生产,易携带,食用方便等优点,能够在感到不适时及时服用,缓解症状。目前,市场上还未见有改善呼吸道免疫力的可食用的口含片产品。
发明内容
本发明的目的是克服现有技术的缺陷,提供一种改善呼吸道免疫力的植物口含片,采用药食同源的草本免疫成分,对身体无毒副作用,能够通过人体多归经调理,综合改善呼吸道免疫力及其紊乱所致的咳嗽、咳痰、乏力、嗜睡、精神不济等症状。
本发明的另外一个目的是提供一种改善呼吸道免疫力的植物口含片的制备工艺,使用直接压片法,成本低且工艺操作省时简单。
实现上述目的一种技术方案是:一种改善呼吸道免疫力的植物口含片,按重量份计,包括以下组分:
所述改善呼吸道免疫力组合物由以下重量份的组分制成:金银花50~150份、陈皮20~80份、余甘子10~50份、甘草10~50份、山药10~30份、薄荷10~30份、显齿蛇葡萄叶10~30份、紫苏籽5~15份、罗汉果5~15份、云南小黄姜1~5份、姜黄12~48份和黑胡椒20~80份。
上述的一种改善呼吸道免疫力的植物口含片,其中,所述糖采用蔗糖、葡萄糖和/或果糖;
所述代糖采用木糖醇、甜菊糖苷和/或赤藓糖醇;
所述增稠剂采用麦芽糊精、淀粉或预胶化淀粉;
所述清凉醇采用薄荷醇;
所述药用辅料采用硬脂酸镁、二氧化硅、滑石粉、聚乙二醇4000、聚乙二醇6000和/或十二烷基硫酸镁。
上述的一种改善呼吸道免疫力的植物口含片,其中,所述改善呼吸道免疫力组合物中的各组分采用生药饮片水提取物或生药饮片超微粉,或者所述改善呼吸道免疫力组合物中的山药采用山药超微粉,剩余的组分采用生药饮片水提取物。
本发明还提供了一种改善呼吸道免疫力的植物口含片的制备工艺,包括以下步骤:
S1,制备改善呼吸道免疫力组合物步骤:所述改善呼吸道免疫力组合物采用水提物提取工艺或超微粉工艺制备而成;或者所述改善呼吸道免疫力组合物中山药采用由超微粉工艺制备得到山药超微粉,其余的组分采用水提物提取工艺制备得到的水提取物冻干粉,然后将山药超微粉和水提取物冻干粉混合后得到所述改善呼吸道免疫力组合物;
S2,将改善呼吸道免疫力组合物、香橼提取物、糖或代糖、增稠剂、清凉醇和药用辅料分别打磨成超微粉形态后,分别过80~200目筛,取通过筛网的粉体备用;
S3,按照如权利要求1所述的植物口含片的配方,将步骤S2中过筛后的改善呼吸道免疫力组合物、香橼提取物、糖或代糖、增稠剂和清凉醇混合均匀;然后再加入硬脂酸镁混合均匀,采用压片机直接压片,最后用包衣机包裹含有水溶性老香橼食用香精的薄膜衣即得改善呼吸道免疫力的植物口含片。
上述的一种改善呼吸道免疫力的植物口含片的制备工艺,步骤S1中,所述改善呼吸道免疫力组合物采用水提物提取工艺制备而成的具体步骤为:按照如权利要求1所述的改善呼吸道免疫力组合物的配方称取各组分的生药饮片,无需捣碎或捣碎后过3目~5目的标准筛,混匀后,加入10~15倍体积的水,90℃~100℃加热回流1.5~3h,得到的提取液使用150目~300目筛过滤,重复加热提取1~3次并过滤,将所有滤液合并,在温度50℃~70℃、真空度70~100mbar的条件下真空浓缩至原有滤液体积的1/5至1/10,然后将浓缩液冷冻干燥得到改善呼吸道免疫力组合物。
上述的一种改善呼吸道免疫力的植物口含片的制备工艺,步骤S1中,所述改善呼吸道免疫力组合物采用超微粉工艺制备而成的具体步骤为:按照如权利要求1所述的改善呼吸道免疫力组合物的配方称取各组分的生药饮片,置于中药打粉机中进行初步粉碎,过4号筛或5号筛,然后采用超微粉碎机进行粉碎得到改善呼吸道免疫力组合物。
上述的一种改善呼吸道免疫力的植物口含片的制备工艺,步骤S1中,山药超微粉和水提取物冻干粉混合得到改善呼吸道免疫力组合物的具体步骤为:
A.按照如权利要求1所述的改善呼吸道免疫力组合物的配方称取各组分的生药饮片;
B.取除山药外的其余组分的生药饮片,无需捣碎或捣碎后过3目~5目的标准筛,混匀后,加入10~15倍体积的水,90℃~100℃加热回流1.5-3h,提取液使用150目~300目筛过滤,重复加热提取1~3次并过滤,将所有滤液合并,在温度50℃~70℃、真空度70~100mbar的条件下真空浓缩至原有滤液体积的1/5至1/10,然后将浓缩液冷冻干燥得到水提取物冻干粉备用;
C.再取山药的生药饮片,置于中药打粉机中进行初步粉碎,过4号筛或5号筛,采用超微粉碎机进行粉碎得到山药超微粉备用;
D.将步骤B中的水提取物冻干粉和步骤C中的山药超微粉混合后置于超微粉碎机中粉碎得到改善呼吸道免疫力组合物。
上述的一种改善呼吸道免疫力的植物口含片的制备工艺,其特征在于,所述超微粉碎机的转速为300~400rpm,粉碎时间20~40min,球料比(5~20):1,大小球的比例为1:(1~6)。
采用本发明的改善呼吸道免疫力的植物口含片及其制备工艺的技术方案,有益效果体现在:
(1)使用的所有成分均为食品级原、辅料,采用药食同源的草本免疫成分,对身体无毒副作用;
(2)综合改善呼吸道免疫力及其紊乱所致的咳嗽、咳痰、乏力、嗜睡、精神不济等症状,且在改善缓解呼吸道感染症状方面起到积极效果的同时不会对身体造成其他损伤;
(3)香橼提取物和清凉醇,使改善呼吸道免疫力的植物口含片含有香橼的果味和薄荷的清凉口感;另外,香橼作为云南特色水果,性温,微酸甜,可以起到疏肝理气,止咳化痰的作用;
(4)口含片可以直接作用口腔、口腔粘膜及舌下腺,快速吸收,改善呼吸道感染症状方面效果显著;
(5)口含片可以直接作用在咽部,由于缓慢的含化,使有效成分能较长时间停留在咽部持续发挥功效,对于缓解咽干、咽痛等不适感觉见效快;
(6)改善呼吸道免疫力组合物中含有山药,山药富含淀粉和黏蛋白,可以发挥粘合剂和崩解剂的效果,既是活性组分又是辅料;
(7)口含片具有含糖版和无蔗糖版两种版本。其中无蔗糖版添加的代糖,热量低,进入血液后不需要胰岛素就能透过细胞,代谢速度快,一般不会引起血糖升高,糖尿病患者也可食用;
(8)口含片的制备工艺使用直接压片法,成本低且工艺操作省时简单。
附图说明
图1为本发明的一种改善呼吸道免疫力的植物口含片的制备工艺的流程图。
具体实施方式
为了使本技术领域的技术人员能更好地理解本发明的技术方案,下面结合附图对其具体实施方式进行详细地说明:
实施例1:
一种改善呼吸道免疫力的植物口含片(含糖版),按重量份计,包括以下组分:
改善呼吸道免疫力组合物由以下重量份的组分制成:金银花100份、陈皮50份、余甘子30份、甘草30份、山药20份、薄荷20份、显齿蛇葡萄叶20份、紫苏籽10份、罗汉果10份、云南小黄姜3份、姜黄30份和黑胡椒50份。
请参阅图1,本实施例的改善呼吸道免疫力的植物口含片,采用以下制备工艺制成:
S1,采用超微粉工艺制备改善呼吸道免疫力组合物,具体步骤为:按照上述的改善呼吸道免疫力组合物的配方称取各组分的生药饮片,置于中药打粉机中进行初步粉碎,过5号筛(180μm±7.6μm,80目),采用超微粉碎机进行粉碎得到改善呼吸道免疫力组合物(超微粉),超微粉碎机的参数为:转速400rpm,时间30min,球料比10:1,大小球(7mm:3mm)=1:4;
S2,将改善呼吸道免疫力组合物(超微粉)、香橼提取物、蔗糖、麦芽糊精、薄荷醇和硬脂酸镁分别打磨成超微粉形态后,分别过100目筛,取通过筛网的粉体备用,得到原料粒径为150μm;
S3,取30份改善呼吸道免疫力组合物(超微粉)、15份香橼提取物、20份蔗糖、30份麦芽糊精和0.2份薄荷醇混合均匀后,再加入0.5份硬脂酸镁混合均匀,用压片机进行压片,再用包衣机对片剂包薄膜衣。其中,包衣预混剂中含0.5份水溶性老香橼食用香精。得到10mm,0.6g/片规格的改善呼吸道免疫力的植物口含片15片。
实施例2:
一种改善呼吸道免疫力的植物口含片(无糖版),按重量份计,包括以下组分:
改善呼吸道免疫力组合物由以下重量份的组分制成:金银花100份、陈皮50份、余甘子30份、甘草30份、山药20份、薄荷20份、显齿蛇葡萄叶20份、紫苏籽10份、罗汉果10份、云南小黄姜3份、姜黄30份和黑胡椒50份。
请参阅图1,本实施例的改善呼吸道免疫力的植物口含片,采用以下制备工艺制成:
S1,采用超微粉工艺制备改善呼吸道免疫力组合物(超微粉),具体步骤为:按照上述的改善呼吸道免疫力组合物的配方称取各组分的生药饮片,置于中药打粉机中进行初步粉碎,过5号筛(180μm±7.6μm,80目),采用超微粉碎机进行粉碎得到改善呼吸道免疫力组合物(超微粉),超微粉碎机的参数为:转速400rpm,时间30min,球料比10:1,大小球(7mm:3mm)=1:4;
S2,将改善呼吸道免疫力组合物(超微粉)、香橼提取物、木糖醇、麦芽糊精、薄荷醇和硬脂酸镁分别打磨成超微粉形态后,分别过100目筛,取通过筛网的粉体备用,得到原料粒径为150μm;
S3,取30份改善呼吸道免疫力组合物(超微粉)、15份香橼提取物、20份木糖醇、30份麦芽糊精和0.2份薄荷醇混合均匀后,再加入0.5份硬脂酸镁混合均匀,用压片机进行压片,再用包衣机对片剂包薄膜衣。其中,包衣预混剂中含0.5份水溶性老香橼食用香精。得到10mm,0.6g/片规格的改善呼吸道免疫力的植物口含片15片。
实施例3:
一种改善呼吸道免疫力的植物口含片(无糖版),按重量份计,包括以下组分:
改善呼吸道免疫力组合物由以下重量份的组分制成:金银花100份、陈皮50份、余甘子30份、甘草30份、山药20份、薄荷20份、显齿蛇葡萄叶20份、紫苏籽10份、罗汉果10份、云南小黄姜3份、姜黄30份和黑胡椒50份。
请参阅图1,本实施例的改善呼吸道免疫力的植物口含片,采用以下制备工艺制成:
S1,改善呼吸道免疫力组合物中山药采用由超微粉工艺制备得到山药超微粉,其余的组分采用水提物提取工艺制备得到的水提取物冻干粉,然后将山药超微粉和水提取物冻干粉混合后得到所述改善呼吸道免疫力组合物的具体步骤为:
A.按照上述的改善呼吸道免疫力组合物的配方称取各组分的生药饮片;
B.取除山药外的其余组分的生药饮片,无需捣碎或捣碎后过3目~5目的标准筛,混匀后,加入10倍体积的水,100℃加热回流3h,提取液使用200目筛过滤,重复加热提取1~3次并过滤,将所有滤液合并,在温度60℃、真空度100mbar的条件下真空浓缩至原有滤液体积的1/10,然后将浓缩液冷冻干燥得到水提取物冻干粉备用;
C.再取山药的生药饮片,置于中药打粉机中进行初步粉碎,5号筛(180μm±7.6μm,80目),采用超微粉碎机进行粉碎得到山药超微粉备用,超微粉碎机的参数为转速400rpm,时间30min,球料比10:1,大小球(7mm:3mm)=1:4;
D.将步骤B中的水提取物冻干粉和步骤C中的山药超微粉按照质量比为19:1的比例混合后置于超微粉碎机中粉碎得到改善呼吸道免疫力组合物,粉碎机参数300rpm,时间5min,球料比5:1,大小球(7mm:3mm)=1:4,这种改善呼吸道免疫力组合物采用除山药外的水提取物冻干粉+山药超微粉的形式;
S2,将改善呼吸道免疫力组合物、香橼提取物、木糖醇、麦芽糊精、薄荷醇和硬脂酸镁分别打磨成超微粉形态后,分别过100目筛,取通过筛网的粉体备用,得到原料粒径为150μm;
S3,取30份改善呼吸道免疫力组合物、15份香橼提取物、20份木糖醇、30份麦芽糊精和0.2份薄荷醇混合均匀后,再加入0.5份硬脂酸镁混合均匀,用压片机进行压片,再用包衣机对片剂包薄膜衣。其中,包衣预混剂中含0.5份水溶性老香橼食用香精。得到10mm,0.6g/片规格的改善呼吸道免疫力的植物口含片15片。
以上各实施例中,改善呼吸道免疫力组合物也可以采用水提物提取工艺制备而成,具体步骤为:按照如权利要求1所述的改善呼吸道免疫力组合物的配方称取各组分的生药饮片,无需捣碎或捣碎后过3目~5目的标准筛,混匀后,加入10~15倍体积的水,90℃~100℃加热回流1.5~3h,得到的提取液使用150目~300目筛过滤,重复加热提取1~3次并过滤,将所有滤液合并,在温度50℃~70℃、真空度70~100mbar的条件下真空浓缩至原有滤液体积的1/5至1/10,然后将浓缩液冷冻干燥得到改善呼吸道免疫力组合物。
改善呼吸道免疫力组合物的功效验证实验:
经过4天10人次的试服试验,在10个症状咳嗽、乏力、精神不济、脑袋反应变慢、气喘或呼吸急促、嗜睡、味觉/嗅觉衰退、咳痰、鼻塞/流鼻涕、情绪低落均有改善趋势,尤其在咳嗽、咳痰、乏力、嗜睡、精神不济等症状方面均具有显著性改善。
人体试服的具体试验过程如下:
干预组的试服人员选取感染后呼吸道不适人员10人进行人体试服本发明的改善呼吸道免疫力组合物,连续试服4天,每个人每天根据症状改善情况进行打分,之后根据打分进行统计分析,评估产品配方的有效性。
同时设置对照组,对照组中选取感染后呼吸道不适人员10人,不服用本发明的改善呼吸道免疫力组合物,根据每个人每天的症状进行打分,之后根据打分进行统计分析。
1.产品形态:袋泡茶(3.8g/袋)形式的改善呼吸道免疫力组合物,由以下重量份的组分制成:金银花100份、陈皮50份、余甘子30份、甘草30份、山药20份、薄荷20份、显齿蛇葡萄叶20份、紫苏籽10份、罗汉果10份、云南小黄姜3份、姜黄30份和黑胡椒50份;
2.服用方法:每人一天2次,每次1袋,用开水冲泡5分钟后服用;
3.干预组的试服人员:10个感染后呼吸道不适的患者;
4.对照组的人员:10个感染后呼吸道不适的患者;
5.打分指标:16个指标—咳嗽、气喘或呼吸急促、咯痰、乏力、嗜睡、鼻塞/流鼻涕、精神不济、失眠、肠胃不适、味觉和嗅觉衰退、咳嗽引起的胸口疼、情绪低落、偶尔眩晕、关节痛、偶尔心慌、脑袋反应变慢,每个指标设置1-5分,分值越小表示症状减轻较多;
6.干预组对呼吸道免疫力紊乱所致症状的改善情况的统计结果见表1:
表1:
表1中,数值表示为均值±标准差(mean±SEM);*表示vs.0Days(与0天的数据相比),P<0.05;**表示vs.0Days(与0天的数据相比),P<0.01;***表示vs.0Days(与0天的数据相比),P<0.001。
7.对照组的呼吸道免疫力紊乱所致症状的情况的统计结果见表2:
表2:
表2中,数值表示为均值±标准差(mean±SEM);#表示vs.1Days(与第1天相比),P<0.05。
通过表1和表2中的数据相比,服用本发明中的改善呼吸道免疫力组合物,对10个症状如咳嗽、乏力、精神不济、脑袋反应变慢、气喘或呼吸急促、嗜睡、味觉/嗅觉衰退、咳痰、鼻塞/流鼻涕和情绪低落,均有改善趋势,尤其在咳嗽、咳痰、乏力、嗜睡、精神不济等症状方面均具有显著性改善效果。
本发明的改善呼吸道免疫力的植物口含片,改善呼吸道免疫力组合物,选取药食同源且具有改善呼吸道免疫力的药味或其提取物,组合物中的金银花、陈皮、甘草、余甘子以达到清热解毒、燥湿化痰、补脾养胃、生津止渴的功效,再配以利湿、化痰止咳、祛痰利咽、补肺气等功效的显齿蛇葡萄叶、紫苏籽、薄荷、云南小黄姜、山药、罗汉果。此外,组合物中再加入对呼吸道免疫力紊乱所致症状具有辅助改善作用的姜黄和黑胡椒,从而综合达到改善呼吸道免疫力的作用。香橼提取物和清凉醇,使改善呼吸道免疫力的植物口含片含有香橼的果味和薄荷的清凉口感;另外,香橼作为云南特色水果,性温,微酸甜,可以起到疏肝理气,止咳化痰的作用;山药富含淀粉和黏蛋白,可以发挥粘合剂和崩解剂的效果,既是活性组分又是辅料。
本发明的改善呼吸道免疫力的植物口含片,采用药食同源的草本免疫成分,对身体无毒副作用,能够通过人体多归经调理,综合改善呼吸道免疫力及其紊乱所致的咳嗽、咳痰、乏力、嗜睡、精神不济等症状,另外,症状主要集中在上呼吸道,尤其是咳嗽、咯痰、咽干、咽痛等,相对于咀嚼片或崩解片,口含片可以直接作用在口腔及咽部,通过口腔粘膜及舌下腺快速吸收;同时,含化过程可以使有效成分能较长时间停留在口腔及咽部持续发挥功效,维持久,见效快。口含片具有含糖版和无蔗糖版两种版本,其中无蔗糖版添加的代糖,热量低,进入血液后不需要胰岛素就能透过细胞,代谢速度快,一般不会引起血糖升高,糖尿病患者也可食用。口含片的制备工艺使用直接压片法,成本低且工艺操作省时简单。
综上所述,本发明的改善呼吸道免疫力的植物口含片及其制备工艺,采用药食同源的草本免疫成分,对身体无毒副作用,能够通过人体多归经调理,综合改善呼吸道免疫力及其紊乱所致的咳嗽、咳痰、乏力、嗜睡、精神不济等症状。且使用直接压片法制备,成本低且工艺操作省时简单。
本技术领域中的普通技术人员应当认识到,以上的实施例仅是用来说明本发明,而并非用作为对本发明的限定,只要在本发明的实质精神范围内,对以上所述实施例的变化、变型都将落在本发明的权利要求书范围内。
Claims (8)
1.一种改善呼吸道免疫力的植物口含片,其特征在于,按重量份计,包括以下组分:
改善呼吸道免疫力组合物 20~30份;
香橼提取物 15~20份;
糖或代糖 20~30份;
麦芽糊精、淀粉或预胶化淀粉 30~40份;
清凉醇 0.2~0.4份;
硬脂酸镁 0.5~1份;
水溶性老香橼食用香精 0.5~1.5份;
所述改善呼吸道免疫力组合物由以下重量份的组分制成:金银花50~150份、陈皮20~80份、余甘子10~50份、甘草10~50份、山药10~30份、薄荷10~30份、显齿蛇葡萄叶10~30份、紫苏籽5~15份、罗汉果5~15份、云南小黄姜1~5份、姜黄12~48份和黑胡椒20~80份。
2.如权利要求1所述的一种改善呼吸道免疫力的植物口含片,其特征在于,所述糖采用蔗糖、葡萄糖和/或果糖;
所述代糖采用木糖醇、甜菊糖苷和/或赤藓糖醇;
所述清凉醇采用薄荷醇;
所述硬脂酸镁采用二氧化硅、滑石粉、聚乙二醇4000、聚乙二醇6000和/或十二烷基硫酸镁替代。
3.如权利要求1所述的一种改善呼吸道免疫力的植物口含片,其特征在于,所述改善呼吸道免疫力组合物中的各组分采用生药饮片水提取物或生药饮片超微粉,或者所述改善呼吸道免疫力组合物中的山药采用山药超微粉,剩余的组分采用生药饮片水提取物。
4.一种如权利要求1所述的改善呼吸道免疫力的植物口含片的制备工艺,其特征在于,包括以下步骤:
S1,制备改善呼吸道免疫力组合物步骤:所述改善呼吸道免疫力组合物采用水提物提取工艺或超微粉工艺制备而成;或者所述改善呼吸道免疫力组合物中山药采用由超微粉工艺制备得到山药超微粉,其余的组分采用水提物提取工艺制备得到的水提取物冻干粉,然后将山药超微粉和水提取物冻干粉混合后得到所述改善呼吸道免疫力组合物;
S2,将改善呼吸道免疫力组合物、香橼提取物、糖或代糖、麦芽糊精、淀粉或预胶化淀粉、清凉醇和硬脂酸镁分别打磨成超微粉形态后,分别过80~200目筛,取通过筛网的粉体备用;
S3,按照如权利要求1所述的植物口含片的配方,将步骤S2中过筛后的改善呼吸道免疫力组合物、香橼提取物、糖或代糖、麦芽糊精、淀粉或预胶化淀粉和清凉醇混合均匀;然后再加入硬脂酸镁混合均匀,采用压片机直接压片,最后用包衣机包裹含有水溶性老香橼食用香精的薄膜衣即得改善呼吸道免疫力的植物口含片。
5.如权利要求4所述的一种改善呼吸道免疫力的植物口含片的制备工艺,其特征在于,步骤S1中,所述改善呼吸道免疫力组合物采用水提物提取工艺制备而成的具体步骤为:按照如权利要求1所述的改善呼吸道免疫力组合物的配方称取各组分的生药饮片,无需捣碎或捣碎后过3目~5目的标准筛,混匀后,加入10~15倍体积的水,90℃~100℃加热回流1.5~3h,得到的提取液使用150目~300目筛过滤,重复加热提取1~3次并过滤,将所有滤液合并,在温度50℃~70℃、真空度70~100mbar的条件下真空浓缩至原有滤液体积的1/5至1/10,然后将浓缩液冷冻干燥得到改善呼吸道免疫力组合物。
6.如权利要求4所述的一种改善呼吸道免疫力的植物口含片的制备工艺,其特征在于,步骤S1中,所述改善呼吸道免疫力组合物采用超微粉工艺制备而成的具体步骤为:按照如权利要求1所述的改善呼吸道免疫力组合物的配方称取各组分的生药饮片,置于中药打粉机中进行初步粉碎,过4号筛或5号筛,然后采用超微粉碎机进行粉碎得到改善呼吸道免疫力组合物。
7.如权利要求4所述的一种改善呼吸道免疫力的植物口含片的制备工艺,其特征在于,步骤S1中,山药超微粉和水提取物冻干粉混合得到改善呼吸道免疫力组合物的具体步骤为:
A.按照如权利要求1所述的改善呼吸道免疫力组合物的配方称取各组分的生药饮片;
B.取除山药外的其余组分的生药饮片,无需捣碎或捣碎后过3目~5目的标准筛,混匀后,加入10~15倍体积的水,90℃~100℃加热回流1.5-3h,提取液使用150目~300目筛过滤,重复加热提取1~3次并过滤,将所有滤液合并,在温度50℃~70℃、真空度70~100mbar的条件下真空浓缩至原有滤液体积的1/5至1/10,然后将浓缩液冷冻干燥得到水提取物冻干粉备用;
C.再取山药的生药饮片,置于中药打粉机中进行初步粉碎,过4号筛或5号筛,采用超微粉碎机进行粉碎得到山药超微粉备用;
D.将步骤B中的水提取物冻干粉和步骤C中的山药超微粉混合后置于超微粉碎机中粉碎得到改善呼吸道免疫力组合物。
8.如权利要求6或7所述的一种改善呼吸道免疫力的植物口含片的制备工艺,其特征在于,所述超微粉碎机的转速为300~400rpm,粉碎时间20~40min,球料比(5~20):1,大小球的比例为1:(1~6)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310295065.2A CN116492437B (zh) | 2023-03-24 | 2023-03-24 | 一种改善呼吸道免疫力的植物口含片及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310295065.2A CN116492437B (zh) | 2023-03-24 | 2023-03-24 | 一种改善呼吸道免疫力的植物口含片及其制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116492437A CN116492437A (zh) | 2023-07-28 |
CN116492437B true CN116492437B (zh) | 2023-12-12 |
Family
ID=87320912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310295065.2A Active CN116492437B (zh) | 2023-03-24 | 2023-03-24 | 一种改善呼吸道免疫力的植物口含片及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116492437B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101543296A (zh) * | 2009-05-04 | 2009-09-30 | 昆明七彩云花生物科技有限公司 | 用食用植物及其提取物制备的含片 |
CN104027440A (zh) * | 2014-04-28 | 2014-09-10 | 张聪聪 | 止咳化痰含片及其制备方法 |
CN114681568A (zh) * | 2020-12-30 | 2022-07-01 | 石家庄以岭药业股份有限公司 | 一种止咳化痰组合物、代用茶、糖果及制备方法 |
-
2023
- 2023-03-24 CN CN202310295065.2A patent/CN116492437B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101543296A (zh) * | 2009-05-04 | 2009-09-30 | 昆明七彩云花生物科技有限公司 | 用食用植物及其提取物制备的含片 |
CN104027440A (zh) * | 2014-04-28 | 2014-09-10 | 张聪聪 | 止咳化痰含片及其制备方法 |
CN114681568A (zh) * | 2020-12-30 | 2022-07-01 | 石家庄以岭药业股份有限公司 | 一种止咳化痰组合物、代用茶、糖果及制备方法 |
Non-Patent Citations (1)
Title |
---|
保健型佛手香橼含片的研制;许洁玲;江乙逵;陈宇;许思昭;王燕儿;;现代食品科技(第05期);56, 57 * |
Also Published As
Publication number | Publication date |
---|---|
CN116492437A (zh) | 2023-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102599318B (zh) | 一种滇橄榄润喉糖及其制备方法 | |
CN103392852A (zh) | 一种护嗓化痰的雪梨茶及其制备方法 | |
CN104906347B (zh) | 一种金梅果含片及其制作方法和应用 | |
CN104115959A (zh) | 一种保健茶饮料 | |
CN100577024C (zh) | 赤藓糖醇的夹心巧克力 | |
CN112314819A (zh) | 一种改善睡眠的植物饮料及其制备方法 | |
CN105362384B (zh) | 一种解酒醒酒的中药组合物及其应用 | |
CN108174945B (zh) | 一种针对吸烟者的清咽食品及其制备方法 | |
CN103372047A (zh) | 一种杜仲含片及其制备方法 | |
CN106723029A (zh) | 一种具有辅助降血糖功能的保健食品及其制备工艺 | |
CN104041649A (zh) | 一种含中药植物提取物的口气清新润喉糖及其制备方法 | |
CN106389587A (zh) | 一种清润保健花茶及其制备工艺 | |
CN104474472B (zh) | 具有降三高作用的苦丁茶含片及其生产方法 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN116616395A (zh) | 一种改善呼吸道免疫力的植物固体饮料及其制备工艺 | |
CN116492437B (zh) | 一种改善呼吸道免疫力的植物口含片及其制备工艺 | |
CN104305193B (zh) | 具有促进肠推进作用的食品及其制备方法 | |
CN110179931B (zh) | 一种养心安神组合物及其制备方法 | |
CN104383232B (zh) | 清热解毒苦丁茶含片及其生产方法 | |
CN107361281B (zh) | 一种罗汉果泡腾片及其制备方法 | |
CN114681568A (zh) | 一种止咳化痰组合物、代用茶、糖果及制备方法 | |
CN112168944A (zh) | 预防新冠肺炎的中药组合物、提取物、其制备方法及应用 | |
CN111789206A (zh) | 一种枇杷饮品制剂及其制备方法 | |
CN111529642A (zh) | 一种儿童中药棒棒膏及其制作方法 | |
CN117158504A (zh) | 一种改善呼吸道免疫力的植物软糖及其制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |